Excess Abdominal Fat Clinical Trial
Official title:
Clinical Assessment to Evaluate UltraShape Power Device Performance for Flanks Fat Reduction
Prospective, baseline-controlled evaluation of the UltraShape Power device for non-invasive fat reduction in flanks.
Eligible subjects will receive 3 bi-weekly treatments (2 weeks interval) with the UltraShape
Power device according to the study protocol.
One random flank will be treated with one pass or remained as a control (no treatment) while
the second flank will be treated with multiple passes.
Subjects will return for up to 4 follow up visits: 4 weeks, 8 weeks, 12 weeks and (optional)
24 weeks following end of treatment/s.
Each subject will be enrolled for total expected study duration of up to 28 weeks.
After last follow up visit, subjects who wish will receive compensation treatments (up to 3)
on the flank who received regular treatment (single pass) or remained as a control (no
treatment).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02748928 -
UltraShape Power for Abdominal Fat and Circumference Reduction
|
N/A | |
| Recruiting |
NCT02700152 -
Clinical Study to Evaluate the Safety and Efficacy of the UltraShape Device for Non-Invasive Abdominal Fat Reduction
|
N/A |